No evidence for shorter leukocyte telomere length in parkinson's disease patients

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 11, 2010, Pages 1181-1184

  Eerola, Johanna ^a,b   Kananen, Laura ^a   Manninen, Kaisa ^a   Hellström, Olli ^c   Tienari, Pentti J ^a,b   Hovatta, Iiris ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Parkinson's disease; Telomere

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; FEMALE; GENETICS; HUMAN; LEUKOCYTE; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; STATISTICAL MODEL; TELOMERE; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LEUKOCYTES; LINEAR MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; TELOMERE;

EID: 77958066363     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq125     Document Type: Article

References (24)

1. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373:2055-2066.
2. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008;7:97-109.
3. Dickson DW. Linking selective vulnerability to cell death mechanisms in Parkinson's disease. Am J Pathol. 2007;170:16-19.
4. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;38:518-520.
5. Thomas P, O'Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev. 2008;129:183-190.
6. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339-344.
7. Cipriano C, Tesei S, Malavolta M, et al. Accumulation of cells with short telomeres is associated with impaired zinc homeostasis and infammation in old hypertensive participants. J Gerontol A Biol Sci Med Sci. 2009;64:745-751.
8. Ilmonen P, Kotrschal A, Penn DJ. Telomere attrition due to infection. PLoS One. 2008;3:e2143.
9. Carrero JJ, Stenvinkel P, Fellstrom B, et al. Telomere attrition is associated with infammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med. 2008;263: 302-312.
10. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifes the association of leukocyte telomere length with insulin resistance and infammation. J Clin Endocrinol Metab. 2006; 91:635-640.
11. Guan JZ, Maeda T, Sugano M, et al. A percentage analysis of the telomere length in Parkinson's disease patients. J Gerontol A Biol Sci Med Sci. 2008;63:467-473.
12. Wang H, Chen H, Gao X, et al. Telomere length and risk of Parkinson's disease. Mov Disord. 2008;23:302-305. (Pubitemid 351311569)
13. Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N. Aging-associated alteration of subtelomeric methylation in Parkinson's disease. J Gerontol A Biol Sci Med Sci. 2009;64:949-955.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
15. Eerola J, Tienari PJ, Kaakkola S, Nikkinen P, Launes J. How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry. 2005;76:1211-1216.
16. Clarimon J, Eerola J, Hellstrom O, Peuralinna T, Tienari PJ, Singleton AB. Assessment of PINK1 (PARK6) polymorphisms in Finnish PD. Neurobiol Aging. 2006;27:906-907.
17. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47.
18. Kananen L, Surakka I, Pirkola S, et al. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One. 2010;5:e10826.
19. Bakaysa SL, Mucci LA, Slagboom PE, et al. Telomere length predicts survival independent of genetic infuences. Aging Cell. 2007;6:769-774.
20. Kimura M, Hjelmborg JV, Gardner JP, et al. Telomere length and mortality: a study of leukocytes in elderly Danish twins. Am J Epidemiol. 2008;167:799-806.
21. Franco S, Blasco MA, Siedlak SL, et al. Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? Alzheimers Dement. 2006;2:164-168.
22. Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement. 2009;5:463-469.
23. Zhang D, Cheng L, Craig DW, Redman M, Liu C. Cerebellar telomere length and psychiatric disorders. Behav Genet. 2010;40:250-254.
24. Takubo K, Izumiyama-Shimomura N, Honma N, et al. Telomere lengths are characteristic in each human individual. Exp Gerontol. 2002;37:523-531.